FRIDAY, DECEMBER 9, 2016

Viread shows efficacy against hepatitis B

Officials with Gilead Sciences recently released data from an ongoing study of Viread, a treatment for chronic hepatitis B infection. Read More »

Effort to control malaria may be more effective than eradication

An expert team of researchers reports that an effort to control malaria may be more effective than the eradication efforts posed by the World Health Organization. Read More »

Texas sees rise in whooping cough infections

Health officials in Texas are urging people to be vaccinated against pertussis, or whooping cough, as the illness spreads throughout the state. Read More »

Expiremental malaria vaccine enters late stage testing

Mosquirix, an experimental malaria vaccine made by the British biopharmaceutical company Glaxosmithkline, is undergoing late stage testing, with results expected by 2011. Read More »

Report shows toll H1N1 took on California children

A report recently issued by the California Department of Health states that one quarter of children in California who were hospitalized by the H1N1 flu in 2009 were taken to intensive care units or died. Read More »

Emergent BioSolutions, Inc. acquires Trubion Pharmaceuticals

Emergent BioSolutions, Inc., of Rockville, Maryland, recently announced that it had completed the acquisition of Trubion Pharmaceuticals, Inc. Read More »

Haitian cholera found to be similar to South Asian outbreak strain

The U.S. Centers for Disease Control has found that the cholera strain in the Haiti outbreak is very similar to a strain from a South Asian outbreak. Read More »

Zimbabwe health minister calls for new TB strategies

New strategies must be created to deal with multi-drug resistant and extensively drug-resistant tuberculosis in Africa, Zimbabwe's health and child welfare minister announced recently. Read More »

Medical investigators researching whooping cough vaccine

Medical investigators recently traveled to California, which is experiencing its worst pertussis, or whooping cough, outbreak in the last 60 years, to study the effectiveness of a vaccine that has been in use since 1997. Read More »

Inviragen receives grants for dengue, chikungunya vaccines

The biotechnology company Inviragen announced on November 2 that it has received two grants totaling $488,958 from a recently established U.S. government program to fight dengue fever and chikungunya virus. Read More »

Study shows that monotheraphy more effective in fighting flu

A randomized, placebo-controlled trial has shown that a combination of the drugs oseltamivir - tamiflu - and zanamivir - relenza - is less effective than oseltamivir monotherapy and it is not significantly more effective than a zanamivir monotherapy. Read More »

Study says Telbivudine may stop transmission of hepatitis B to infants

The results of a recent study showed the drug Telbivudine stopped the transmission of hepatitis B to infants. Read More »

Britain saw highest TB levels for 30 years in 2009

Government data have shown that there were 9,040 cases of tuberculosis in Britain in 2009 - the highest level of TB in 30 years - and that drug-resistant cases have nearly doubled in the last decade. Read More »

WHO finds bivalent oral polio vaccine more effective than trivalent vaccine

A World Health Organization study in India showed that bivalent oral poliovirus vaccines for types 1 and 3 poliovirus were more effective than a trivalent oral poliovirus vaccine for types 1, 2 and 3 in newborn babies. Read More »

Dayton, Ohio facing increase in whooping cough cases

Dayton, Ohio, has been hit by a wave of pertussis, or whooping cough, cases, especially among children. Read More »

WHO says dengue fever is a neglected disease

Despite being one of the most rapidly growing mosquito-borne illness in the world and being under intense media scrutiny in recent years, the World Health Organization considers dengue fever be to a neglected disease. Read More »

Vaccination rates lagging in children with commercial health plans

Rates of vaccination among children insured by commercial health plans dropped almost four percent between 2008 and 2009, while the vaccination rates among children on Medicaid is rising, a recent report has revealed. Read More »

Vaccine shows progress against meningitis B

New data has shown that antibodies created by the Novartis 4CMenB vaccine killed most of a collection of genetically and geographically diverse meningococcal serogroup B - meningitis B - strains. Read More »

H5N1 vaccine enters Phase II human clinical trials

Health Canada has recently cleared the biopharmaceutical company Medicago, Inc., to begin Phase II human clinical trials of its H5N1 avian influenza vaccine. Read More »

California county reports three West Nile Virus cases

Health officials in San Bernardino County, California, announced this week that three human cases of West Nile Virus have been reported. Read More »